Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
about
Role of annexins in endocytosis of antigens in immature human dendritic cellsPros and Cons of Antigen-Presenting Cell Targeted Tumor VaccinesContribution of dendritic cells to the autoimmune pathology of systemic lupus erythematosusSuppression of acute lung inflammation by intracellular peptide delivery of a nuclear import inhibitorInfluenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.Binding and activation of major histocompatibility complex class II-deficient macrophages by staphylococcal exotoxins.Campylobacter jejuni induces maturation and cytokine production in human dendritic cells.Dendritic cells during Staphylococcus aureus infection: subsets and roles.Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality.HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagationDistinct mechanisms of immunosuppression as a consequence of major surgeryTargeting dendritic cells for priming cellular immune responses.The tetraspanin CD9 mediates lateral association of MHC class II molecules on the dendritic cell surfaceIntradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to virusesRevenge of the microbes. Superantigens of the T and B cell lineageThe peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situDendritic cell-derived exosomes in cancer immunotherapy: exploiting nature's antigen delivery pathway.Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells.Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses.Dendritic cells but not B cells present antigenic complexes to class II-restricted T cells after administration of protein in adjuvant.Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo.Antigen-dependent and -independent Ca2+ responses triggered in T cells by dendritic cells compared with B cells.Contact sensitizers modulate mechanisms of receptor-mediated endocytosis but not fluid-phase endocytosis in murine epidermal Langerhans cells.Superantigen-mediated differentiation of bovine monocytes into dendritic cellsEffective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.Hormonal Modulation of Dendritic Cells Differentiation, Maturation and Function: Implications for the Initiation and Progress of Systemic Autoimmunity.Presentation of mycobacterial antigens by human dendritic cells: lack of transfer from infected macrophages.The endocytic activity of dendritic cells.Human T-cell responses to Mycoplasma arthritidis-derived superantigen.Comparison of cytotoxic T-lymphocyte responses to hepatitis C virus core protein in uninfected and infected individuals.Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.Dendritic Cell-Based Cancer Vaccines.Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells.Porcine dendritic cells generated in vitro: morphological, phenotypic and functional propertiesMyeloid Dendritic Cells Induce HIV Latency in Proliferating CD4 T Cells
P2860
Q24316546-06F53931-CCE2-4E83-90C1-C3DA1D0F1D42Q27013679-6F8AE2F4-1145-4B39-8A83-12CC16FEB3FEQ28080920-6C31F3E5-9077-4547-AA7B-1A3CA248B5BBQ33713477-CFD345A8-3CEC-4F43-A0DA-FD184602A03BQ34229490-C1CF3AA8-6E20-470A-B95B-674B13544B5FQ34537412-1A03B300-4518-4F3D-A30A-A10D4F2EA351Q34601738-33CE03B6-2E70-4665-923F-3AD93A4F0483Q34788587-1E931B8F-3A79-4640-9162-355331AB4F52Q35097527-120BAECD-1B86-4C3D-988C-6A854514AE86Q35525543-4AC475CC-93F6-43F1-99A3-B3EC637D93D5Q35549389-39DED081-FAF6-400D-80C3-19E5D521F93CQ35549421-CE567E64-B608-46F5-BF30-B04B7A20FE09Q35575949-7468F25B-21C1-476B-8DD8-1524E0B7EC2CQ35793550-5CB50963-86F4-4DA5-9EFC-2F0C6FDD9328Q35833626-B52E4CBC-3295-4822-A74A-E13DD2D17AF6Q36183661-5DCEC58A-06ED-4F93-A6CB-9E9D4E20085DQ36185636-32334E85-B573-4ED2-8C01-1BC7311717E0Q36365562-5BEDBB5E-0CE0-41E5-8D56-4D2F049920ECQ36365628-0F22C87F-0E66-4752-9255-C14161B535E6Q36365918-24DA8978-9B8A-41E8-83ED-F32B1BC645E4Q36366130-F42AC52B-DED0-4571-A9FC-A381C0958F59Q36367475-FDA3A885-35CF-4C36-A85D-AFC7C5056004Q36404256-F285EDEB-DBEC-4FD6-BF60-A7E62DE09537Q36788110-925B0B58-C235-4CC8-9A3B-06E6179E86FCQ37130175-1F59FBBB-7B6E-4EB9-A9C2-F09C3D49CB65Q37399694-D8EC5351-E064-4DC5-9AAC-17E64C5A3315Q38944092-25CABCC2-4EA0-478C-8873-2AFCF8E71DDDQ40269946-8D67AECA-47D5-4336-B275-8B8FBABD54B7Q40457008-8179AEC7-991A-458E-BA54-2E6656F2CF18Q42930535-68BFE83E-ADCE-4311-8DE7-9FC748EA1272Q42994713-FF7A85DF-60FE-4901-B8C0-F477A1153DE9Q43967044-9443F6C1-3809-4629-8D14-CFFC7D9A71ABQ48293590-653CE37D-7D5A-453B-83E5-0A8CB7852D2DQ53251883-69D225B3-21C5-4DDD-97EB-01316AA2C564Q56775510-853002D7-A28B-49C0-82B9-63D1B1EEACBBQ58003754-5379D207-5885-4F88-B8ED-43AD6F72D7EF
P2860
Small amounts of superantigen, when presented on dendritic cells, are sufficient to initiate T cell responses.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Small amounts of superantigen, ...... to initiate T cell responses.
@ast
Small amounts of superantigen, ...... to initiate T cell responses.
@en
type
label
Small amounts of superantigen, ...... to initiate T cell responses.
@ast
Small amounts of superantigen, ...... to initiate T cell responses.
@en
prefLabel
Small amounts of superantigen, ...... to initiate T cell responses.
@ast
Small amounts of superantigen, ...... to initiate T cell responses.
@en
P2093
P2860
P356
P1476
Small amounts of superantigen, ...... to initiate T cell responses.
@en
P2093
A J Nisanian
N Bhardwaj
R M Steinman
P2860
P304
P356
10.1084/JEM.178.2.633
P407
P577
1993-08-01T00:00:00Z